Ensysce Biosciences (ENSC) Misses Q4 EPS by 290c

March 10, 2025 5:00 PM

Ensysce Biosciences (NASDAQ: ENSC) reported Q4 EPS of ($2.90).

For earnings history and earnings-related data on Ensysce Biosciences (ENSC) click here.